Ionis Pharmaceuticals, Inc. (IONS)
76.85
+1.60
(+2.13%)
USD |
NASDAQ |
May 06, 16:00
76.84
-0.02
(-0.02%)
After-Hours: 20:00
Ionis Pharmaceuticals Cash from Investing (Quarterly) : 536.82M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
| Biogen, Inc. | -209.50M |
| Mirum Pharmaceuticals, Inc. | 1.006M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -792.82M |
| Cash from Financing (Quarterly) | 57.26M |
| Free Cash Flow | -977.73M |
| Free Cash Flow Per Share (Quarterly) | -4.950 |
| Free Cash Flow to Equity (Quarterly) | -811.39M |
| Free Cash Flow to Firm (Quarterly) | -793.52M |
| Free Cash Flow Yield | -7.61% |